Okumura H, Araragi Y, Nishioka K, Yamashita R, Suzuki T, Watanabe H, et al
Still, researchers emphasise that longer phase 3 studies with larger populations will be required to fully rule out any rare risks that might not show up in smaller trials
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems
A Role for Uric Acid in the Progression of Renal Disease
Your prescriber may recommend: Temporarily maintaining your current dose for an additional week or two before escalating, allowing more time for adaptation Anti-emetic medication for severe nausea (such as domperidone or metoclopramide, which should only be used short-term and under medical supervision due to potential side effects) Laxatives for constipation or anti-diarrhoeal agents for persistent diarrhoea Dose reduction or treatment discontinuation if side effects remain intolerable despite supportive measures Seek urgent medical attention if you experience severe abdominal pain (particularly if radiating to the back), persistent vomiting preventing fluid intake, signs of pancreatitis, or symptoms of gallbladder disease
(Triple Agonist Explained) Retatrutide (also known as LY3437943) is a triple receptor agonist , meaning it interacts with: GLP-1 receptors (appetite & insulin signalling) GIP receptors (metabolic regulation) Glucagon receptors (energy expenditure pathways) Most older compounds target one or two pathways
